Omnipaque 180 mg I/ml injektioneste, liuos Финландия - фински - Fimea (Suomen lääkevirasto)

omnipaque 180 mg i/ml injektioneste, liuos

ge healthcare as - iohexol - injektioneste, liuos - 180 mg i/ml - joheksoli

Omnipaque 140 mg I/ml injektioneste, liuos Финландия - фински - Fimea (Suomen lääkevirasto)

omnipaque 140 mg i/ml injektioneste, liuos

ge healthcare as - iohexol - injektioneste, liuos - 140 mg i/ml - joheksoli

OMNIPAQUE 200 mg I/ml injektioneste, liuos Финландия - фински - Fimea (Suomen lääkevirasto)

omnipaque 200 mg i/ml injektioneste, liuos

amersham health as - iohexolum - injektioneste, liuos - 200 mg i/ml - joheksoli

Ultra Technekow Fm 2.15-43.00 GBq radionuklidigeneraattori Финландия - фински - Fimea (Suomen lääkevirasto)

ultra technekow fm 2.15-43.00 gbq radionuklidigeneraattori

curium netherlands b.v. - sodium molybdate - radionuklidigeneraattori - 2.15-43.00 gbq - teknetium(99mtc)perteknetaatti

Tekcis 2-50 GBq radionuklidigeneraattori Финландия - фински - Fimea (Suomen lääkevirasto)

tekcis 2-50 gbq radionuklidigeneraattori

cis bio international - sodium pertechnetate (99mtc) - radionuklidigeneraattori - 2-50 gbq - teknetium(99mtc)perteknetaatti

Ervebo Европейски съюз - фински - EMA (European Medicines Agency)

ervebo

merck sharp & dohme b.v.  - yhdistelmä-vesicular stomatitis-virus, (kanta indiana), jossa poistetaan kirjekuori glykoproteiini, korvataan zaire ebolavirus (kanta kikwit 1995) pinta-glykoproteiinin - verenvuotokuume ebola - rokotteet - ervebo is indicated for active immunization of individuals 1 year of age or older to protect against ebola virus disease (evd) caused by zaire ebola virus. käyttö ervebo pitäisi olla virallisten suositusten mukaisesti.

Melatonin Unimedic Pharma 1 mg/ml oraaliliuos Финландия - фински - Fimea (Suomen lääkevirasto)

melatonin unimedic pharma 1 mg/ml oraaliliuos

unimedic pharma ab - melatonin - oraaliliuos - 1 mg/ml - melatoniini

Sivextro Европейски съюз - фински - EMA (European Medicines Agency)

sivextro

merck sharp & dohme b.v. - tedisolidifosfaatti - soft tissue infections; skin diseases, bacterial - antibacterials for systemic use, , other antibacterials - sivextro is indicated for the treatment of acute bacterial skin and skin structure infections (absssi) in adults and adolescents 12 years of age and older.

Clopidogrel Acino Европейски съюз - фински - EMA (European Medicines Agency)

clopidogrel acino

acino ag - klopidogreeli - peripheral vascular diseases; acute coronary syndrome; myocardial infarction; stroke - antitromboottiset aineet - clopidogrel is indicated in adults for the prevention of atherothrombotic events in: , , , patients suffering from myocardial infarction (from a few days until less than 35 days), ischaemic stroke (from 7 days until less than 6 months) or established peripheral arterial disease, non-st segment elevation acute coronary syndrome (unstable angina or non-q-wave myocardial infarction), including patients undergoing a stent placement following percutaneous coronary intervention, in combination with acetylsalicylic acid (asa), st segment elevation acute myocardial infarction, in combination with asa in medically treated patients eligible for thrombolytic therapy, patients suffering from acute coronary syndrome. , ,.

Clopidogrel Acino Pharma Европейски съюз - фински - EMA (European Medicines Agency)

clopidogrel acino pharma

acino pharma gmbh - klopidogreeli - peripheral vascular diseases; stroke; myocardial infarction - antitromboottiset aineet - klopidogreeli on tarkoitettu aikuisille aterotromboottisten tapahtumien estämiseen:potilaalla on ollut sydäninfarkti (josta on muutama vuorokausi, mutta enintään 35 vuorokautta), iskeeminen aivohalvaus (josta on 7 vuorokautta, mutta alle 6 kuukautta) tai perifeerinen valtimosairaus. lisätietoja, katso kohta 5.